Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

Transplant Proc. 2003 Nov;35(7):2687-8. doi: 10.1016/j.transproceed.2003.08.042.
No abstract available

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation / immunology*
  • Lamivudine / therapeutic use*
  • Liver Function Tests
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Postoperative Complications / virology*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Safety

Substances

  • Immunosuppressive Agents
  • Reverse Transcriptase Inhibitors
  • Lamivudine